Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1982 1
1983 1
1984 1
1985 1
1986 3
1987 2
1988 2
1989 5
1990 4
1991 11
1992 14
1993 12
1994 9
1995 11
1996 13
1997 19
1998 20
1999 24
2000 26
2001 26
2002 30
2003 52
2004 37
2005 45
2006 46
2007 54
2008 52
2009 52
2010 61
2011 54
2012 71
2013 75
2014 78
2015 109
2016 108
2017 124
2018 101
2019 112
2020 101
2021 94
2022 102
2023 104
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

1,662 results

Results by year

Filters applied: . Clear all
Page 1
Synucleinopathies.
Lamotte G, Singer W. Lamotte G, et al. Handb Clin Neurol. 2023;196:175-202. doi: 10.1016/B978-0-323-98817-9.00032-6. Handb Clin Neurol. 2023. PMID: 37620069 Review.
The alpha-synucleinopathies include pure autonomic failure, multiple system atrophy, dementia with Lewy bodies, and Parkinson disease. ...
The alpha-synucleinopathies include pure autonomic failure, multiple system atrophy, dementia with Lewy bodies, and Par …
Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature.
Bougea A. Bougea A. Int J Mol Sci. 2023 Mar 9;24(6):5281. doi: 10.3390/ijms24065281. Int J Mol Sci. 2023. PMID: 36982356 Free PMC article. Review.
Multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are uncommon multifactorial atypical Parkinsonian syndromes, expressed by various clinical features. ...
Multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) are uncommon multifactorial atypical Parkinsonia …
Predicting the Prognosis of Multiple System Atrophy Using Cluster and Principal Component Analysis.
Du J, Cui S, Huang P, Gao C, Zhang P, Liu J, Li H, Huang M, Shen X, Liu Z, Chen Z, Tan Y, Chen S. Du J, et al. J Parkinsons Dis. 2023;13(6):937-946. doi: 10.3233/JPD-225127. J Parkinsons Dis. 2023. PMID: 37522217 Free PMC article.
BACKGROUND: Multiple system atrophy (MSA) is an intractable neurodegenerative disorder with poorly understanding of prognostic factors. ...
BACKGROUND: Multiple system atrophy (MSA) is an intractable neurodegenerative disorder with poorly understanding of pro …
The genetic basis of multiple system atrophy.
Tseng FS, Foo JQX, Mai AS, Tan EK. Tseng FS, et al. J Transl Med. 2023 Feb 10;21(1):104. doi: 10.1186/s12967-023-03905-1. J Transl Med. 2023. PMID: 36765380 Free PMC article. Review.
Multiple system atrophy (MSA) is a heterogenous, uniformly fatal neurodegenerative -synucleinopathy. ...
Multiple system atrophy (MSA) is a heterogenous, uniformly fatal neurodegenerative -synucleinopathy. ...
Multiple system atrophy.
Wenning GK, Geser F. Wenning GK, et al. Rev Neurol (Paris). 2003 May;159(5 Pt 2):3S31-8. Rev Neurol (Paris). 2003. PMID: 12773886 Review.
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early fifties and progresses relentlessly with a mean survival of 9 years. ...
Multiple system atrophy (MSA) is a sporadic neurodegenerative disorder that usually manifests in the early fifties and …
Pathomechanisms of depression in multiple system atrophy.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2023 Jan;130(1):1-6. doi: 10.1007/s00702-022-02560-y. Epub 2022 Nov 8. J Neural Transm (Vienna). 2023. PMID: 36348076 Review.
Multiple system atrophy (MSA) is a rapidly progressing neurodegenerative disorder of uncertain etiology that is characterized by various combinations of Parkinsonism, autonomic, cerebellar and motor dysfunctions, with poor prognosis. ...
Multiple system atrophy (MSA) is a rapidly progressing neurodegenerative disorder of uncertain etiology that is charact …
Mild cognitive impairment in multiple system atrophy: a brain network disorder.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2023 Oct;130(10):1231-1240. doi: 10.1007/s00702-023-02682-x. Epub 2023 Aug 15. J Neural Transm (Vienna). 2023. PMID: 37581647 Review.
Cognitive impairment (CI), previously considered as a non-supporting feature of multiple system atrophy (MSA), according to the second consensus criteria, is not uncommon in this neurodegenerative disorder that is clinically characterized by a variable combin …
Cognitive impairment (CI), previously considered as a non-supporting feature of multiple system atrophy (MSA), accordin …
Neurofilament light levels predict clinical progression and death in multiple system atrophy.
Chelban V, Nikram E, Perez-Soriano A, Wilke C, Foubert-Samier A, Vijiaratnam N, Guo T, Jabbari E, Olufodun S, Gonzalez M, Senkevich K, Laurens B, Péran P, Rascol O, Le Traon AP, Todd EG, Costantini AA, Alikhwan S, Tariq A, Ng BL, Muñoz E, Painous C, Compta Y, Junque C, Segura B, Zhelcheska K, Wellington H, Schöls L, Jaunmuktane Z, Kobylecki C, Church A, Hu MTM, Rowe JB, Leigh PN, Massey L, Burn DJ, Pavese N, Foltynie T, Pchelina S, Wood N, Heslegrave AJ, Zetterberg H, Bocchetta M, Rohrer JD, Marti MJ, Synofzik M, Morris HR, Meissner WG, Houlden H. Chelban V, et al. Brain. 2022 Dec 19;145(12):4398-4408. doi: 10.1093/brain/awac253. Brain. 2022. PMID: 35903017 Free PMC article.
Neurofilament light chain protein has been explored as a reliable biomarker in several neurodegenerative disorders but data on multiple system atrophy have been limited. Therefore, neurofilament light chain is not yet routinely used as an outcome measure in …
Neurofilament light chain protein has been explored as a reliable biomarker in several neurodegenerative disorders but data on multiple …
Morbidity and mortality in orthostatic hypotension.
Farrell MC, Shibao CA. Farrell MC, et al. Auton Neurosci. 2020 Dec;229:102717. doi: 10.1016/j.autneu.2020.102717. Epub 2020 Aug 17. Auton Neurosci. 2020. PMID: 32896712 Review.
Finally, we also review the epidemiology of nOH based on the underlying neurodegenerative disorder (either Parkinson's disease or multiple system atrophy), and the presence of co-morbid conditions such as hypertension and cognitive impairment....
Finally, we also review the epidemiology of nOH based on the underlying neurodegenerative disorder (either Parkinson's disease or multipl …
Surface-Based Neuroimaging Pattern of Multiple System Atrophy.
Wang Z, Mo J, Zhang J, Feng T, Zhang K. Wang Z, et al. Acad Radiol. 2023 Dec;30(12):2999-3009. doi: 10.1016/j.acra.2023.04.014. Epub 2023 Jul 24. Acad Radiol. 2023. PMID: 37495425
RATIONALE AND OBJECTIVES: Overlapping parkinsonism, cerebellar ataxia, and pyramidal signs render challenges in the clinical diagnosis of multiple system atrophy (MSA). The neuroimaging pattern is valuable to understand its pathophysiology and improve its dia …
RATIONALE AND OBJECTIVES: Overlapping parkinsonism, cerebellar ataxia, and pyramidal signs render challenges in the clinical diagnosis of …
1,662 results